CAP1 Antibody - BSA Free

Western Blot: CAP1 Antibody [NBP1-58320]

Western Blot: CAP1 Antibody [NBP1-58320] - THP-1 cell lysate, concentration 0.2-1 ug/ml.

Immunohistochemistry: CAP1 Antibody [NBP1-58320]

Immunohistochemistry: CAP1 Antibody [NBP1-58320] - Formalin Fixed Paraffin Embedded Tissue: Human heart Tissue Observed Staining: Plasma membrane Primary Antibody Concentration: N/A Other Working Concentrations: 1:600 Secondary Antibody: Donkey anti-Rabbit-Cy3 Secondary Antibody Concentration: 1:200 Magnification: 20X Exposure Time: 0.5 - 2.0 sec

Western Blot: CAP1 Antibody - BSA Free [NBP1-58320] -

CAP1 is down‐regulated during terminal erythroid differentiation. A, A representative diagram of erythroid populations in E14.5 foetal livers, analysed by flow cytometry with antibodies against CD71 and Ter119. B‐D, R1 to R4 cell populations showed in (A) were sorted by flow cytometry. The mRNA levels of beta‐globin (B), pri‐miR‐144/451 (C) and Cap1 (D) were then determined by real‐time RT‐PCR assays. 18S (B & D) or U6 (C) rRNAs were used as the internal reference controls. E, Western blotting analyses of CAP1 protein levels in R1 to R4 cell populations. F, Gross view of the cell pellets from D0 and D2 in vitro differentiated foetal liver erythroid cells. G, D0 and D2 in vitro cultured foetal liver cells were stained with APC‐Ter119 and Hoechst 33342. Representative plots of flow cytometry were shown on the left and averaged percentage of Ter119high/Hoechstlow population from 3 independent experiments on the right. H, Relative expression levels of beta‐globin, pri‐miR‐144/451 and Cap1 from D0 and D2 in vitro cultured foetal liver cells. B‐D, E, G, H, All data are presented as mean +/- SEM from at least three biological replicates (*P < .05; **P < .01; ***P < .001) Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/33496386), licensed under a CC-BY license. Not internally tested by Novus Biologicals.